Hologic (HOLX) PT Raised to $48 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
Go back to Hologic (HOLX) PT Raised to $48 at RBC Capital
January 31, 2019 8:21 AM EST
Needham & Company analyst Mike Matson raised the price target on Hologic (NASDAQ: HOLX) to $50.00 (from $48.00) while maintaining a Buy rating.
Matson commented, " HOLX's F4Q18 revenue was consistent with its 1/7/19 preannouncement while EPS beat consensus. Management raised its FY19 revenue and EPS guidance.... More
January 31, 2019 8:18 AM EST
Cowen analyst Doug Schenkel raised the price target on Hologic (NASDAQ: HOLX) to $46.00 (from $43.00) while maintaining a Market Perform rating.
...
More
January 31, 2019 6:21 AM EST
UBS raised its price target on Hologic (NASDAQ: HOLX) to $47.00 (from $44.00) while maintaining a Neutral rating.
...
More
January 30, 2019 4:02 PM EST
Hologic (NASDAQ: HOLX) reported Q1 EPS of $0.58, $0.01 better than the analyst estimate of $0.57. Revenue for the quarter came in at $830.7 million versus the consensus estimate of $817.94 million.
GUIDANCE:
Hologic sees Q2 2019 EPS of $0.55-$0.57, versus the consensus of... More
